CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement Impact of Artificial Intelligence on Interventional Cardiology: From Decision-Making Aid to Advanced Interventional Procedure Assistance Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD

Review ArticleVolume 10, Issue 3, February 2017

JOURNAL:JACC: Cardiovascular Interventions Article Link

Management of No-Reflow Phenomenon in the Catheterization Laboratory

Rezkalla SH, Stankowski RV, Hanna J et al. Keywords: ST-segment elevation myocardial infarction; no-reflow; percutaneous coronary intervention

FULL TEXT PDF